

Anti Active Gα13 Mouse Monoclonal Antibody
- CR-M26902
- 科博瑞生物
- 湖北省武汉市
- 现货
- 30ul
- 4800 元
- 2024-06-12 15:24:20
科博瑞(武汉)生物科技有限公司
一键申请试用
咨询
加入意向单
联系方式
- 种属
- Mouse
Active Gα13 GTP [CR-M26902]
[30 µL]
Catalog Number: CR-M26902 |
Gene Symbol: Gna13 |
Description: Anti Active Gα13 Mouse Monoclonal Antibody
|
Background: Heterotrimeric G proteins are essential cellular signal transducers. Gα13 is one of the G proteins that could mediate cell migration and angiogenesis. Other biochemical and physiological functions of Gα13 are being explored. |
Immunogen: Recombinant full length active Gα13 protein |
Applications: IP, IHC |
Recommended Dilutions: 1 µg for 1~2 mg total cellular proteins for IP; 1:100 dilution for IHC |
Concentration: 1 mg/ml |
Host: mouse |
Format: Liquid |
Clonality: Monoclonal |
Isotype: IgG2b |
Purity: Purified from ascites |
Storage buffer: |
Preservative: no |
Constituents: PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 50% glycerol |
Species Reactivity: Anti active Gα13 monoclonal antibody recognizes active Gα13 of vertebrates. |
Storage Conditions: Store at -20°C. Avoid freeze / thaw cycles |
Immunoprecipitation/Western blot: |
![]() |
IP/WB analysis of active Gα13 proteins. Purified Gα13 proteins were treated with GDP (lane 1) or GTPGTPγS (lane 2). After immunoprecipitation with anti active Gα13 GTP mouse monoclonal antibody (Cat. # CR-M26902), these proteins were separated by SDS/PAGE and western blotted with anti Gα13 mouse monoclonal antibody (Cat. # CR-M26004). |
Immunohistochemistry: |
![]() |
Staining of MEF cells (treated with PDGF) with anti Ga13 GTP monoclonal antibody showing the localization of Gα13 GTP in the leading edge of migrating cells. |
Publications: |
1. Resistance to inhibitors of cholinesterase-8A (Ric-8A) is critical for growth factor receptor-induced actin cytoskeletal reorganization J Biol Chem. 2011 Sep 2;286(35):31055-61 |
2. Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Galpha and beta-arrestin-2 Br J Pharmacol. 2011 Feb;162(3):733-48 |
3. Gα12/13 inhibition enhances the anti-cancer effect of bortezomib through PSMB5 downregulation Carcinogenesis (2010) |
4. Suppression of tumor angiogenesis by Galpha(13) haploinsufficiency J Biol Chem. 2009 Oct 2;284(40):27409-15 |